Yan Xia

2.0k total citations · 1 hit paper
75 papers, 1.4k citations indexed

About

Yan Xia is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Yan Xia has authored 75 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 17 papers in Oncology and 13 papers in Surgery. Recurrent topics in Yan Xia's work include Neuroscience and Neuropharmacology Research (10 papers), Myasthenia Gravis and Thymoma (4 papers) and RNA modifications and cancer (4 papers). Yan Xia is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Myasthenia Gravis and Thymoma (4 papers) and RNA modifications and cancer (4 papers). Yan Xia collaborates with scholars based in China, United States and Japan. Yan Xia's co-authors include Kenneth M. Johnson, Cheng Z. Wang, Colleen M. Niswender, Chong Wang, Raymond C. Stevens, Hyekyung P. Cho, P. Jeffrey Conn, Vsevolod Katritch, Gye Won Han and Vadim Cherezov and has published in prestigious journals such as Science, Circulation and Journal of Neuroscience.

In The Last Decade

Yan Xia

69 papers receiving 1.4k citations

Hit Papers

Structure of a Class C GPCR Metabotropic Glutamate Recept... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Xia China 20 788 532 136 115 114 75 1.4k
Fuminori Tsuruta Japan 15 1.4k 1.8× 303 0.6× 168 1.2× 146 1.3× 118 1.0× 37 1.8k
Byron D. Ford United States 25 791 1.0× 476 0.9× 247 1.8× 153 1.3× 130 1.1× 50 1.8k
Mootaz M. Salman United Kingdom 18 888 1.1× 499 0.9× 57 0.4× 100 0.9× 98 0.9× 29 1.9k
Pratap Karki United States 26 601 0.8× 326 0.6× 75 0.6× 173 1.5× 120 1.1× 61 1.4k
Penny Roon United States 25 1.1k 1.3× 313 0.6× 113 0.8× 69 0.6× 51 0.4× 35 2.1k
Qinghuan Xiao China 24 1.5k 2.0× 449 0.8× 255 1.9× 88 0.8× 162 1.4× 44 2.0k
Uwe Pfeil Germany 24 823 1.0× 383 0.7× 132 1.0× 79 0.7× 44 0.4× 54 1.5k
San‐Hua Fang China 27 859 1.1× 343 0.6× 110 0.8× 231 2.0× 132 1.2× 56 1.8k
Venugopalan D. Nair United States 22 936 1.2× 331 0.6× 100 0.7× 126 1.1× 189 1.7× 51 1.6k
Vicki Waetzig Germany 23 1.2k 1.5× 536 1.0× 170 1.3× 250 2.2× 180 1.6× 38 2.1k

Countries citing papers authored by Yan Xia

Since Specialization
Citations

This map shows the geographic impact of Yan Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Xia more than expected).

Fields of papers citing papers by Yan Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Xia. The network helps show where Yan Xia may publish in the future.

Co-authorship network of co-authors of Yan Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Xia. A scholar is included among the top collaborators of Yan Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Xia. Yan Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Xiaoxiang, Jie Liu, E Xiang, et al.. (2025). The Pivotal Role of GR‐CAR Pathway in Fetal Programming of Hepatic Cytochrome P450 3A Alteration in Adulthood. Advanced Science. 13(6). e15583–e15583.
2.
Xia, Yan, et al.. (2024). Programmed cell death-ligand 2: new insights in cancer. Frontiers in Immunology. 15. 1359532–1359532. 7 indexed citations
3.
Sun, Xiaoxiang, Zhengyuan Xie, Zheng He, et al.. (2024). Association between pyrrolizidine alkaloids exposure and risk of abnormal serum indices—Insights from a descriptive cross-sectional study in Yunnan Province. Journal of Hazardous Materials. 480. 136352–136352. 1 indexed citations
4.
Xia, Yan, et al.. (2024). Astragaloside IV confronts amyloid-beta-induced astrocyte senescence via hsp90aa1. Journal of Applied Biomedicine. 22(3). 129–135. 2 indexed citations
5.
Ning, Zhouyu, Ying Zhu, Lin Xie, et al.. (2024). Exploring the efficacy and safety of drug-eluting beads transarterial chemoembolization in pancreatic cancer liver metastasis. British Journal of Radiology. 97(1157). 1010–1015.
6.
Xia, Yan, et al.. (2023). Lenvatinib inhibits intrahepatic cholangiocarcinoma via Gadd45a-mediated cell cycle arrest. Discover Oncology. 14(1). 26–26. 7 indexed citations
7.
Xia, Yan, Liping Zhuang, Zhouyu Ning, Peng Wang, & Zhiqiang Meng. (2021). Addition of thermal ablation to systemic chemotherapy for the treatment of unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis. Expert Review of Gastroenterology & Hepatology. 16(1). 81–88. 5 indexed citations
10.
Hu, Bing, et al.. (2018). Herbal formula YGJDSJ inhibits anchorage-independent growth and induces anoikis in hepatocellular carcinoma Bel-7402 cells. BMC Complementary and Alternative Medicine. 18(1). 17–17. 13 indexed citations
11.
Zhang, Yong, Yanyan Zhang, Hao Li, et al.. (2017). Increased expression of P2X7 receptor in peripheral blood mononuclear cells correlates with clinical severity and serum levels of Th17-related cytokines in patients with myasthenia gravis. Clinical Neurology and Neurosurgery. 157. 88–94. 24 indexed citations
12.
Hu, Bing, et al.. (2016). Teng-Long-Bu-Zhong-Tang decoction promotes cell senescence of human colon carcinoma RKO cells and its possible mechanism. Tumori. 36(12). 1307–1311. 2 indexed citations
13.
Oida, Kumiko, Akira Matsuda, Kyungsook Jung, et al.. (2014). Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells. Scientific Reports. 4(1). 4057–4057. 49 indexed citations
14.
Xia, Yan, Yeling Lu, Jing Dai, et al.. (2012). Molecular basis of type I antithrombin deficiency in two women with recurrent venous thromboembolism in the first trimester of pregnancy. Blood Cells Molecules and Diseases. 48(4). 254–259. 8 indexed citations
15.
Zhang, Hao, Qin Fang, Wei Ye, et al.. (2011). Revealing the Drug‐Resistant Mechanism for Diarylpyrimidine Analogue Inhibitors of HIV‐1 Reverse Transcriptase. Chemical Biology & Drug Design. 78(3). 427–437. 5 indexed citations
16.
Xia, Yan, George S. Portugal, Amanda K. Fakira, et al.. (2011). Hippocampal GluA1-Containing AMPA Receptors Mediate Context-Dependent Sensitization to Morphine. Journal of Neuroscience. 31(45). 16279–16291. 41 indexed citations
17.
Xia, Yan, Cheng Z. Wang, Jie Liu, Noelle C. Anastasio, & Kenneth M. Johnson. (2009). Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways. Neuropharmacology. 58(2). 330–336. 50 indexed citations
18.
Xia, Yan, et al.. (2005). Determination of tripterine in Tripterygium wilfordii and its tablets by HPLC. Zhongcaoyao. 2 indexed citations
19.
Xia, Yan. (2005). Advances in studies on medicinal plants of Tripterygium Hook.f.. Zhongcaoyao. 2 indexed citations
20.
Xia, Yan, et al.. (2003). Taurine depletion reduces the neuroprotective effects of electroacupuncture against brain ischemia. 19(1). 32–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026